
个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
雷增杰,医学博士/博士后,科主任助理,副主任医师,副教授,硕士研究生导师。现任东部战区总医院肿瘤科科主任助理、副主任医师;江苏省“333工程”培养对象,军队优秀专业技术人才岗位津贴,联保部队重点学科后备学科带头人;以第一作者或通讯作者在Cancer Research, Oncogene和Cancer Letters等杂志发SCI表论文20余篇,获得国家专利5项,参与编写专著多部;主持国家自然科学基金等项目4项;多次获嘉奖、优秀教师及优秀带教老师称号。主要学术任职:中国光学工程学会理事、中国光学工程学会微纳光学专委会委员、江苏省抗癌协会肿瘤复发与转移专业委员会青年委员和江苏省抗癌协会胃癌专业委员会青年委员。专业领域:1、消化系统肿瘤(食管癌、胃癌、结直肠癌等)化疗、靶向和免疫治疗临床及科研工作。2、其他恶性肿瘤的综合治疗。
国家自然科学基金青年基金,21万元,在研,主持
江苏省自然科学基金青年基金,20万元,在研,主持
江苏省博士后科研资助计划,5万元,在研,主持
中国博士后科学基金新冠肺炎疫情防控专项资助,12万元,在研,主持
1. Zhou J, Lei Z, Chen J, et al. Nuclear export ofBATF2 enhances colorectal cancer proliferation through binding to CRM1. ClinTransl Med. 2023;13(5) (IF: 10,第一作者)
2. Zhu J, Ji L, Chen Y, Li H, Huang M, Dai Z, Wang J,Xiang D, Fu G, Lei Z, Chu X.Organoids and organs-on-chips: insights into predicting the efficacy ofsystemic treatment in colorectal cancer. Cell Death Discov. 2023 Feb22;9(1):72. (IF: 7.109,共同通讯作者)
3. Chen Y, Han C, Huang Y, Liu C, Sheng S, Ji L, ZhuJ, Fu G, Mao X, Huang M, Lei Z, ChuX. The incidence of second primary cancer in male and female patients withinitial colorectal cancer: a SEER population-based study. Eur J Cancer Prev.2022 Sep 1;31(5):430-441. (IF: 2.164,共同通讯作者)
4. Huang Y, Ji L,Zhu J, Mao X, Sheng S, Hao S, Xiang D, Guo J, Fu G, Huang M, Lei Z, Chu X. Lymph node status and itsimpact on the prognosis of left-sided and right-sided colon cancer: A SEERpopulation-based study. Cancer Med. 2021 Oct 26. doi: 10.1002/cam4.4357.(IF: 4.711,共同通讯作者)
5. Chen Y, HuangM, Liu X, Huang Y, Liu C, Zhu J, Fu G, LeiZ, Chu X. Alternative splicing of mRNA in colorectal cancer: new strategiesfor tumor diagnosis and treatment. Cell Death Dis. 2021 Jul 30;12(8):752. (IF:9.685,共同通讯作者)
6. Liu C, Huang M, Han C, Li H, Wang J, Huang Y, ChenY, Zhu J, Fu G, Yu H, Lei Z, Chu X.A narrative review of the roles of muscle segment homeobox transcription factorfamily in cancer. Ann Transl Med 2021;9(9):810.(IF: 3.616,共同通讯作者)
7. Wu M, Huang M,He C, Chen C, Li H, Wang J, Liu M, Fu G, LeiZ, Chu X.. Risk of Second Primary Malignancies Based on the HistologicalSubtypes of Colorectal Cancer. Frontiers in oncology. 2021;11:650937. (IF: 6.244, 共同通讯作者)
8. Chen, Y. #, Wang, T. #, Huang, M. #, Liu, Q. #, Hu,C. #, Wang, B., Han, D., Chen, C., Zhang, J., Li, Z., Liu, C., Lei, Z., Chang,Y., Wu, M., Xiang, D., Chen, Y., Wang, R., Huang, W., Lei, Z*., & Chu, X*. (2020). MAFB Promotes Cancer Stemness andTumorigenesis in Osteosarcoma through a Sox9-Mediated Positive FeedbackLoop. Cancer research, 80(12), 2472–2483(IF: 13.312,共同通讯作者)
9. Tang X-Y, Huang M-X, Han S-Q,Chang Y, Li Z-P, Kao X-M, Chen Y-Y, Liu C, Huang Y-D, Chen Y-T, Lei Z-J and Chu X-Y (2020) TheCircumferential Resection Margin Is a Prognostic Predictor in ColonCancer. Front. Oncol. 10:927. (IF: 6.244,共同通讯作者)
10. Li, Z. P., Liu, X. Y., Kao, X. M., Chen, Y. T.,Han, S. Q., Huang, M. X., Liu, C., Tang, X. Y., Chen, Y. Y., Xiang, D., Huang,Y. D., Lei, Z. J., & Chu, X. Y.(2020). Clinicopathological characteristics and prognosis of colorectalmucinous adenocarcinoma and nonmucinous adenocarcinoma: a surveillance,epidemiology, and end results (SEER) population-based study. Annals oftranslational medicine, 8(5), 205. (IF: 3.689,共同通讯作者)
11. Han D#, Huang M#, Wang T#, Li Z, Chen Y, Liu C, Lei Z*, Chu X*: Lysine methylation oftranscription factors in cancer. Celldeath & disease 2019, 10(4). (IF: 9.685,共同通讯作者)
12. Huang M#, Chen Y#, Han D, Lei Z *, ChuX *.Role of the zinc finger and SCAN domain-containing transcriptionfactors in cancer[J].American journal of cancer research,2019,9(5):816-836. (IF: 6.166,共同通讯作者)
13. Shi, M. Huang, D. Han, X. Tang, Y. Chen, Z. Li, C.Liu, D. Xiang, T. Wang, Y. Chen, R. Wang, Z.Lei, X. Chu, Chemotherapy is associated with increased survival fromcolorectal signet ring cell carcinoma with distant metastasis: A Surveillance,Epidemiology, and End Results database analysis, Cancer medicine, 8 (2019)1930-1940. (IF: 4.711,共同通讯作者)
14. T. Wang, H#. Wu, S#. Liu, Z#. Lei, Z#. Qin,L.. Wang, SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2activation and cancer stem cell maintenance. Cancer letters (2018).S0304-3835(18)30322-7(IF: 9.756,共同第一作者)
15. Huang M#, Chen C#, Geng J, Han D, Wang T, Xie T,Wang L, Wang Y, Wang C, Lei Z*, Chu X*.Targeting KDM1A attenuatesWnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-likecells in hepatocellular carcinoma. Cancer Lett.2017; 398:12-21(IF: 9.756,共同通讯作者)
16. LeiZJ#, Wang J#, Xiao HL, Guo Y, Wang T, Li Q, Liu L, Luo X, Fan LL, Lin L,Mao CY, Wang SN, Wei YL, Lan CH, Jiang J, Yang XJ, Liu PD, Chen DF*, Wang B*.Lysine-specific demethylase 1 promotes the stemness and chemoresistance ofLgr5(+) liver cancer initiating cells by suppressing negative regulators ofbeta-catenin signaling. Oncogene. 2015; 34: 3188-98(IF: 9.867,第一作者)
上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg文件上传中...